Start Date
April 30, 2012
Primary Completion Date
December 31, 2012
Study Completion Date
December 31, 2012
droxidopa
Oral, 100, 200, 300, 400, 500, or 600 mg TID, duration includes two crossover periods of up to a 2 week titration period followed by a 4 week treatment period,with a washout between crossover periods.
Henry Ford West Bloomfield Hospital, West Bloomfield
University of Alberta, Movement Disorders Clinic Glenrose Rehabilitation Hospital, Edmonton
Lead Sponsor
Chelsea Therapeutics
INDUSTRY